38 Grants (Page 1 of 2)
2017
LXR as a Novel Therapeutic Target in Diabetic Retinopathy
Boulton, Michael E⋅BUSIK, JULIA V and GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 7R01EY025383-03), $555,127USD, 09/01/2017 -- 08/31/2019
2016
LXR as a novel therapeutic target in diabetic retinopathy
Boulton, Michael E⋅BUSIK, JULIA V and GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 5R01EY025383-02), $532,879USD, 09/01/2015 -- 08/31/2019
 
Optimizing systemic stem/progenitor cell therapy for AMD
Boulton, Michael E and GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 4R01EY023629-04), $489,698USD, 09/30/2013 -- 08/31/2018
 
OPTIMIZING SYSTEMIC STEM/PROGENITOR CELL THERAPY FOR AMD
Boulton, Michael E and GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 7R01EY023629-05), $546,187USD, 09/30/2013 -- 08/31/2018
2015
Bone Marrow Neuropathy Drives Diabetic Retinopathy
ABCOUWER, STEVEN F⋅GRANT, MARIA B and MOHR, SUSANNE
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 5R01EY007739-25), $452,377USD, 09/07/2013 -- 08/31/2017
 
LXR as a novel therapeutic target in diabetic retinopathy
Boulton, Michael E⋅BUSIK, JULIA V and GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 1R01EY025383-01A1), $582,429USD, 09/01/2015 -- 08/31/2019
 
Optimizing systemic stem/progenitor cell therapy for AMD
Boulton, Michael E and GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 5R01EY023629-03), $515,942USD, 09/30/2013 -- 08/31/2018
 
Vascular Reparative Mechanism by ACE2/Ang-(1-7)in Diabetes
GRANT, MARIA B
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL110170-05), $438,812USD, 09/01/2011 -- 06/30/2016
2014
Dysfunction of endothelial precursor subtypes dictates the outcomes of diabetic r
GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 5R01EY012601-16), $365,756USD, 09/01/2013 -- 05/31/2015
 
Optimizing systemic stem/progenitor cell therapy for AMD
Boulton, Michael E and GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 5R01EY023629-02), $513,987USD, 09/30/2013 -- 08/31/2018
 
Vascular Reparative Mechanism by ACE2/Ang-(1-7)in Diabetes
GRANT, MARIA B
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL110170-04), $436,585USD, 09/01/2011 -- 06/30/2016
2013
Bone Marrow Neuropathy Drives Diabetic Retinopathy
ABCOUWER, STEVEN F⋅GRANT, MARIA B and MOHR, SUSANNE
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 7R01EY007739-23), $517,609USD, 09/07/2013 -- 08/31/2016
 
Dysfunction of endothelial precursor subtypes dictates the outcomes of diabetic r
GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 7R01EY012601-15), $368,011USD, 09/01/2013 -- 05/31/2015
 
NO Dysregulation of the Peripheral Clock in Diabetic Complications
GRANT, MARIA B
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 7R01DK090730-04), $324,529USD, 09/30/2010 -- 08/31/2015
 
Optimizing systemic stem/progenitor cell therapy for AMD
Boulton, Michael E and GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 1R01EY023629-01), $589,587USD, 09/30/2013 -- 08/31/2018
 
Vascular Reparative Mechanism by ACE2/Ang-(1-7)in Diabetes
GRANT, MARIA B
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 7R01HL110170-03), $424,113USD, 09/01/2011 -- 06/30/2016
2012
Bone marrow neuropathy drives diabetic retinopathy
ABCOUWER, STEVEN F⋅GRANT, MARIA B and MOHR, SUSANNE
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 2R01EY007739-22), $519,583USD, 08/01/1989 -- 08/31/2013
 
Dysfunction of endothelial precursor subtypes dictates the outcomes of diabetic r
GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 5R01EY012601-14), $347,437USD, 09/30/1998 -- 07/15/2013
 
NO Dysregulation of the Peripheral Clock in Diabetic Complications
GRANT, MARIA B
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5R01DK090730-03), $299,608USD, 09/30/2010 -- 08/31/2013
 
Vascular Reparative Mechanism by ACE2/Ang-(1-7)in Diabetes
GRANT, MARIA B and Raizada, Mohan K
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL110170-02), $445,394USD, 09/01/2011 -- 06/30/2013
2011
Circulating Progenitors determine angiogenic outcome in diabetic retinopathy
GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 5R01EY007739-21), $352,659USD, 08/01/1989 -- 07/31/2012
 
NO Dysregulation of the Peripheral Clock in Diabetic Complications
GRANT, MARIA B
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5R01DK090730-02), $299,824USD, 09/30/2010 -- 08/31/2014
 
Vascular Reparative Mechanism by ACE2/Ang-(1-7)in Diabetes
GRANT, MARIA B and Raizada, Mohan K
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL110170-01), $468,745USD, 09/01/2011 -- 06/30/2016
2010
ACE2 as a target for pulmonary hypertension therapeutics
GRANT, MARIA B and Raizada, Mohan K
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5RC1HL099980-02), $496,575USD, 09/30/2009 -- 08/31/2012
 
Circulating Progenitors determine angiogenic outcome in diabetic retinopathy
GRANT, MARIA B
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 5R01EY007739-20), $360,112USD, 08/01/1989 -- 12/31/2011